The third PHARMCHINA forum for MAH development new opportunities and challenges co－hosted by HOPE pharmaceutical was successfully concluded at chongqing international expo center on December 5, 2019.

This forum around the MAH status quo combing and future trend analysis, MAH project investment risk analysis, MAH system holders legal risk analysis, MAH quality system set up key points of the four links, plus from the perspective of product registration on the impact of MAH variety selection, for investors to do actual battle MAH system "popular science". At the same time, the forum invited the marketing major to give a wonderful speech on "practical analysis of volume procurement and future clinical variety selection and marketing strategy".

The forum invited the MAH chain in each link of senior experts to answer questions on the spot, at the same time in the forum interspersed with a series of selected varieties to promote, to recommend investors with potential value of differentiated characteristic varieties, to help MAH become agents of the sword. The sea step medicine also carried on the project road show on the forum.

Founded in April 2005, Beijing HOPE pharmaceutical technology co., ltd. is a high_tech enterprise engaged in the research and development, production and sales of chemical drugs.

HOPE pharmaceutical business covers the r&d, registration and customized production of high_end apis and pharmaceutical intermediates, r&d, technology transfer and technical services of pharmaceutical preparations. Research and development of products related to the mental nerve, such as anti_depression, anti_anxiety, sleep disorders, anti_epilepsy, analgesia, anti_tumor, cardiovascular, digestive, respiratory and other indications.

On the basis of chemical generic drugs, HOPE pharmaceutical has made a series of achievements in the technical innovation of small molecule chemical drugs, such as structural modification, process route optimization and innovation, challenging crystal type and process patent. The company has realized the commercial production and sales of more than 10 series of high_end API and intermediates products, and has passed the on_site audit of domestic and foreign customers for many times and won the recognition and praise of customers.

The company has transferred more than 100 projects to pharmaceutical enterprises, and obtained more than 60 production and clinical approval documents. It has long_term and stable cooperative customers, and has accumulated a good reputation in the industry. In the future, HOPE will continue to bring more high_quality projects and provide more comprehensive services.

HOPE pharmaceutical sincerely welcomes all enterprises to negotiate and cooperate!